CompletedNot Applicable

IRIS Ultimaster Cohort in the IRIS-DES Registry

South Korea1,000 participantsStarted 2016-07-20

Plain-language summary

The purpose of this study is to evaluate the relative effectiveness and safety of Ultimaster stent compared to other drug eluting stents.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 19 and more * Intervention with Ultimaster stent * Agreed with written informed consent form Exclusion Criteria: * Intervention with Ultimaster stent and other drug eluting stent at the same time * Life expectancy of 1year and under * Cardiac shock

What they're measuring

Composite event

Timeframe: 1year

Trial details

NCT IDNCT02719106

SponsorDuk-Woo Park, MD

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-07-24

View on ClinicalTrials.gov More Coronary Artery Disease trials